| Comparative effectiveness and safety of monoclonal antibodies (bevacizumab, cetuximab, and panitumumab) in combination with chemotherapy for metastatic colorectal cancer: a … WC Da Silva, VE De Araujo, EMA Lima, JBR Dos Santos, MRR Silva, ... BioDrugs 32 (6), 585-606, 2018 | 47 | 2018 |
| Drug utilization and factors associated with polypharmacy in individuals with diabetes mellitus in Minas Gerais, Brazil MRR Silva, LM Diniz, JBR Santos, EA Reis, AR Mata, VE Araújo, ... Ciência & Saúde Coletiva 23, 2565-2574, 2018 | 32 | 2018 |
| Uso de medicamentos e fatores associados à polifarmácia em indivíduos com diabetes mellitus em Minas Gerais, Brasil MRR Silva, LM Diniz, JBR Santos, EA Reis, AR Mata, VE Araújo, ... Ciência & Saúde Coletiva 23, 2565-2574, 2018 | 27 | 2018 |
| Small molecule CGRP receptor antagonists for the preventive treatment of migraine: a review JBR Dos Santos, MRR da Silva European Journal of Pharmacology 922, 174902, 2022 | 20 | 2022 |
| Comparative effectiveness of adalimumab and etanercept for rheumatoid arthritis in the Brazilian Public Health System JBR Dos Santos, AM Almeida, FA Acurcio, HA de Oliveira Junior, ... Journal of comparative effectiveness research 5 (6), 539-549, 2016 | 18 | 2016 |
| Medication persistence for psoriatic arthritis in a Brazilian real-world setting MR Ribeiro da Silva, JB Ribeiro dos Santos, A Maciel Almeida, A Itria, ... Future science OA 5 (2), FSO369, 2019 | 17 | 2019 |
| Poorer functionality is related to better quality of life response following the use of biological drugs: 6-month outcomes in a prospective cohort from the Public Health System … HA de Oliveira Junior, JB dos Santos, FA Acurcio, AM Almeida, ... Expert Review of Pharmacoeconomics & Outcomes Research 15 (3), 403-412, 2015 | 17 | 2015 |
| Access to high-cost medications for psoriatic arthritis in the National Health System in Brazil: the long path up to dispensation MRR Silva, JBR Santos, AM Almeida, J Alvares-Teodoro, AM Kakehasi, ... Advances in Rheumatology 59, 48, 2019 | 16* | 2019 |
| Biological therapy in the treatment of psoriatic arthritis: economic and epidemiological considerations MRR da Silva, JBR Dos Santos, AM Almeida, AA Guerra Júnior, ... Expert Review of Clinical Immunology 15 (8), 879-887, 2019 | 16 | 2019 |
| Perfil dos usuários com doenças reumáticas e fatores associados à qualidade de vida no sistema único de saúde, Brasil CZ Dias, JBR dos Santos, AM Almeida, JA Teodoro, AAG Júnior, ... Revista Médica de Minas Gerais, 2017 | 16 | 2017 |
| Daridorexant for the treatment of insomnia disorder: findings and implications JBR Dos Santos, MRR da Silva European Journal of Clinical Pharmacology 78 (11), 1749-1761, 2022 | 14 | 2022 |
| First line of biological drugs in rheumatoid arthritis: a medication persistence analysis JBR Dos Santos, AA Guerra Junior, MRR da Silva, AM Almeida, ... Expert review of clinical pharmacology 12 (4), 363-370, 2019 | 13 | 2019 |
| Health-related quality of life in psoriatic arthritis: findings and implications FA Moraes, MRR da Silva, JBR Dos Santos, FA Acurcio, AM Almeida, ... Value in Health Regional Issues 26, 135-141, 2021 | 12 | 2021 |
| Effectiveness and safety of anti-TNF in psoriatic arthritis patients in Brazil: a post-incorporation analysis MRR da Silva, JBR Dos Santos, AM Almeida, AM Kakehasi, ... Journal of Comparative Effectiveness Research 7 (10), 989-1000, 2018 | 10 | 2018 |
| Medication adherence and persistence of psoriatic arthritis patients treated with biological therapy in a specialty pharmacy in Brazil: a prospective observational study AF Souza, MR Da Silva, JB Dos Santos, AM Almeida, FA Acurcio, ... Pharmacy Practice (Granada) 19 (2), 2021 | 8 | 2021 |
| Profile of patients with rheumatic diseases undergoing treatment with anti-TNF agents in the Brazilian Public Health System (SUS), Belo Horizonte-MG HA Oliveira, AM Almeida, FA Acurcio, JB Santos, AM Kakehasi, J Alvares, ... Brazilian Journal of Pharmaceutical Sciences 51 (3), 709-719, 2015 | 7 | 2015 |
| Abdeg technology for the treatment of myasthenia gravis: efgartigimod drug experience JBR Dos Santos, RM Gomes, MRR da Silva Expert Review of Clinical Immunology 18 (9), 879-888, 2022 | 6 | 2022 |
| Cost-utility analysis of the anti-TNF therapy for rheumatoid arthritis in a real-world based model JBR Dos Santos, MRR da Silva, AM Almeida, FDA Acurcio, ... Expert Review of Pharmacoeconomics & Outcomes Research 21 (5), 1011-1016, 2021 | 6 | 2021 |
| Effectiveness and safety of anti-TNF therapy for ankylosing spondylitis: a real-world study PR Kömel Pimenta, MR Ribeiro da Silva, JB Ribeiro dos Santos, ... Journal of Comparative Effectiveness Research 10 (6), 509-517, 2021 | 6 | 2021 |
| Impact of biologic DMARDs on quality of life: 12-month results of a rheumatic diseases cohort using the Brazilian EQ-5D tariff H Alves de Oliveira Junior, T Pereira da Veiga, FDA Acurcio, AM Almeida, ... Hospital Practice 48 (4), 213-222, 2020 | 6 | 2020 |
